Increase in receptor binding affinity for nimodipine in the rat brain with permanent occlusion of bilateral carotid arteries

Life Sciences

Volumn 66, Issue 14, 2000, Pages 1351-1357

  Yamada, Shizuo ^a   Uchida, Shinya ^a,c   Naito, Takafumi ^a   Urayama, Akihiko ^a   Kimura, Ryohei ^a   Murakami, Yukihisa ^b   Matsumoto, Kinzo ^b   Watanabe, Hiroshi ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1,4 DHP calcium channel antagonist receptors; Brain ischemia; Nimodipine

Indexed keywords

CALCIUM CHANNEL; NIMODIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; DRUG RECEPTOR BINDING; IN VIVO STUDY; MALE; MEMORY CONSOLIDATION; NONHUMAN; RAT; RECEPTOR OCCUPANCY;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CAROTID ARTERY, COMMON; CAROTID STENOSIS; ISRADIPINE; MALE; MAZE LEARNING; MYOCARDIUM; NIMODIPINE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0034712330     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00443-4     Document Type: Article

References (22)

1. B.P. Bean, Proc. Natl. Acad. Sci. 81 6388-6392 (1984).
2. S. Kokubun, B. Prod'hom, C. Becker, H. Porzig and H. Reuter, Mol. Pharmacol. 30 571-584 (1986).
3. B.K. Siesjo and F. Bengtsson, J. Cereb. Blood Flow Metab. 9 127-140 (1989).
4. D.W. Choi and S.M. Rothman, Ann. Rev. Neurosci. 13 171-182 (1990).
5. A.M. Hakim and M.J. Hogan, J. Cereb. Blood Flow Metab. 11 762-770 (1991).
6. M.J. Hogan, A. Gjedde and A.M. Hakim, J. Cereb. Blood Flow Metab. 11 771-781 (1991).
7. J.W. Ni, H. Ohta, K. Matsumoto and H. Watanabe, Brain Res. 653 231-236 (1994).
8. J.W. Ni, K. Matsumoto, H.B. Li, Y. Murakami and H. Watanabe, Brain Res. 673 290-296 (1995).
9. T. Kirino, Brain Res. 239 57-69 (1982).
10. W.A. Pulsinelli, J.B. Brierley and F. Plum, Ann. Neurol. 11 491-498 (1982).
11. O.H. Lowry, N.J. Rosebrough, A.L. Farr and R.J. Randall, J. Biol. Chem. 193 265-275 (1951).
12. H.R. Lee, W.R. Roeske and H.I. Yamamura, Life Sci. 35 721-732 (1984).
13. S. Yamada, R. Kimura, Y. Harada and K. Nakayama, J. Pharmacol. Exp. Ther. 252 327-332 (1991).
14. S. Yamada, H.I. Yamamura and W.R. Roeske, J. Pharmacol. Exp. Ther. 215 176-185 (1980).
15. H.E. Rosenthal, Anal. Biochem. 20 525-532 (1967).
16. D.S. Heffez, T.S. Nowak and J.V. Passoneau, J. Neurosurg. 63 589-592 (1985).
17. J.G. Larkin, G.G. Thompson, G. Scobie, G. Forrest, J.E. Drennan and M.J. Brodie, Epilepsia 33 760-769 (1992).
18. L. Cortes, P. Supavilai, M. Karobath and J.M. Palacios, J. Neuronal Transm. 60 169-197 (1984).
19. S. Uchida, S. Yamada, T. Ohkura, M. Heshikiri, A. Yoshimi, H. Shirahase and R. Kimura, Br. J. Pharmacol. 114 217-223 (1995).
20. S. Yamada, S. Uchida, A. Urayama and R. Kimura, Pharmacol. 59 171-182 (1999).
21. S. Yamada and R. Kimura, Cardiovasc. Drug Rev. 14 213-230 (1996).
22. S. Yamada, S. Uchida and R. Kimura, Current Topics in Pharmacol. 4 239-250 (1998).